Casting the Caspase Activity and Apoptosis Inhibitor 1 Phosphoregulation Through Global Phosphoproteomes

View at publisher
Authors: Pathiyil Sajini Sekhar, Amal Fahma, Athira Perunally Gopalakrishnan, Suhail Subair, Leona Dcunha, Althaf Mahin, Samseera Ummar, Prathik Basthikoppa Shivamurthy, Shuvechha Chakraborty, Rajesh Raju
Cited by: 1
References: 58

Abstract

Caspase Activity and Apoptosis Inhibitor 1 (CAAP1) is a regulatory protein known to suppress apoptosis and support cell survival with implications in cancer progression, cell migration, and angiogenesis, yet its regulation at the post-transcriptional level remains poorly understood and is underexplored as a therapeutic target. This study aimed to investigate CAAP1 phosphorylation and its functional significance using global phosphoproteomic datasets. We systematically analyzed 885 human phosphoproteomic profiling and 172 differential expression datasets to identify Class 1 phosphorylation sites (PS) in CAAP1. Co-regulated protein phosphosites were examined to explore CAAP1's biological roles, and enrichment analysis was performed. The four PS, S203, S89, S312, and T90, were the predominantly detected sites. Our results reveal that the PS co-regulated with CAAP1 predominant sites were enriched in splicing-related processes, with strong associations with spliceosome-related proteins and apoptotic regulators. This phosphosite-centric study suggests that CAAP1 phosphoregulatory network is involved in splicing mechanisms, apoptosis regulation, and cancer progression. The study positions CAAP1 phosphorylation in processes frequently dysregulated in cancer and provides a foundation for future translational studies aimed at targeting CAAP1 phosphoregulation as a therapeutic strategy.

Fields of Study & Subjects

Cell death mechanisms and regulation Protein Kinase Regulation and GTPase Signaling ATP Synthase and ATPases Research

Publication details

Journal / source
OMICS A Journal of Integrative Biology
Publisher
SAGE Publications
Volume
30
Issue
4
Pages
224–234
Publication date
17 February 2026
Language
EN